Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

ELRIG Announces Drug Discovery 2013 Preliminary Programme and Call for Posters

Published: Thursday, May 02, 2013
Last Updated: Thursday, May 02, 2013
Bookmark and Share
The 7th Annual Drug Discovery Conference is anticipated to attract over 1000 delegates, engaging scientists involved in early stage drug discovery.

The 2013 programme will contain scientific presentations, an exhibition area with over 100 vendor booths, a networking event, poster sessions, Innovation Zone, Media Area and Careers Zone. Registration for the event is free, and delegates can register online at

The scientific sessions will feature presentations from leading scientists, including the show keynote address from Dr Ruth McKernan, CSO of Pfizer’s Neusentis Unit, on ‘Practical applications of stem cell-derived cells within drug discovery’. The eight scientific sessions are:

• Target & Biomarker Identification & Validation
• Advanced Cell Technologies
In vitro DMPK & Safety Screening
• Macromolecules as Therapeutics
• Innovations in Assay Development & Screening
• Science Led sample Management – putting the horse before the cart
• Oncology Drug Targets – where next?
• Macromolecules as Tools for Discovery & Target Validation

ELRIG is calling for poster abstract submissions, which should be sent to This year a subset of poster abstracts will be selected for 10 minute oral presentations, to be given within the main symposia sessions. Delegates will be given the chance to vote for the best poster, with a prize for the poster receiving the highest number of votes.

In collaboration with SLAS (Society for Laboratory Automation and Screening), students, graduates and post-docs are again invited to submit a poster for entry into the Young Scientist Award, the winner of which will receive a $500 cash prize, as well as an expenses-paid trip to present and participate in the Student Poster Competition at SLAS2014, 18-22 January 2014 in San Diego, CA.

Following on from the success of last year’s Dragons Den,this will also be a feature of the 2013 event.  Companies are encouraged to come forward to pitch to the panel of ‘Dragons’.  To find out more please contact Adrian Kinkaid:

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Approach to Treating Heparin-induced Blood Disorder
A potential treatment for a serious clotting condition that can strike patients who receive heparin to treat or prevent blood clots may lie within reach by elucidating the structure of the protein complex at its root.
Antibody Treatment Efficacious in Psoriasis
An experimental, biologic treatment, brodalumab, achieved 100 percent reduction in psoriasis symptoms in twice as many patients as a second, commonly used treatment, according to the results of a multicenter clinical trial led by Mount Sinai researchers.
Promising Drug Candidate to Treat Chronic Itch
In a new study, scientists from the Florida campus of The Scripps Research Institute (TSRI) describe a class of compounds with the potential to stop chronic itch without the adverse side effects normally associated with medicating the condition.
Escape Prevention
Studying flu virus structure brings us a step closer to a permanent vaccine.
13 Ways to Stop an Unseen Force from Disrupting Weighing
Download a free Mettler Toledo paper to discover how to halt static’s negative effects before the next weigh-in.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.
Researchers Discover A New Mechanism of Proteins to Block HIV
Certain IFITM proteins block and inhibit cell-to-cell transmission of HIV.
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos